CIPLA STOM-ACHE RELIEF DOUBLE STRENGTH hyoscine butylbromide 20mg tablet blister pack

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Ingrédients actifs:

hyoscine butylbromide, Quantity: 20 mg

Disponible depuis:

Cipla Australia Pty Ltd

DCI (Dénomination commune internationale):

Hyoscine butylbromide

forme pharmaceutique:

Tablet, film coated

Composition:

Excipient Ingredients: povidone; microcrystalline cellulose; purified water; lactose monohydrate; magnesium stearate; colloidal anhydrous silica; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350; lecithin

Mode d'administration:

Oral

Unités en paquet:

10

Type d'ordonnance:

(S2) Pharmacy Medicine

indications thérapeutiques:

Spasm of the gastrointestinal tract.

Descriptif du produit:

Visual Identification: Off white, round, biconvex, film coated tablet, plain on both sides; Container Type: Blister Pack; Container Material: PVC/PE/PVDC/Al; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Statut de autorisation:

Licence status A

Date de l'autorisation:

2013-05-31